13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T27093 | CT-1 | CT 1 | p53 |
CT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis. | |||
T5S0636 | Citric acid | Citro,Citretten | Apoptosis , Others , Endogenous Metabolite , Antibacterial , Antibiotic |
1. Citric acid (Citro) (1-2 g/kg) can decrease brain lipid peroxidation and inflammation, liver damage, and DNA fragmentation. 2. Citric acid denture cleansers can reduce C. albicans biofilm accumulation and cell viabili... | |||
T79262 | SSI-4 | Stearoyl-CoA Desaturase (SCD) | |
SSI-4 is a Stearoyl CoA desaturase 1 (SCD1) inhibitor that can be labeled with carbon-11 (11C) for use as a ligand in small animal in vivo PET/CT imaging studies of SCD1 [1]. | |||
T81461 | Pidilizumab | CT-011,MDV9300 | PD-1/PD-L1 |
Pidilizumab (CT-011), a humanized IgG1κ anti-PD-1 monoclonal antibody, serves as a DLL1 antagonist with potential applications in researching hematologic malignancies [1]. | |||
T78153 | PSMA I&T | Others | |
PSMA I&T, a potent inhibitor of prostate-specific membrane antigen (PSMA), facilitates SPECT/CT imaging and radionuclide research in prostate cancer (PCa) [1]. | |||
T74878 | Enzyme-IN-1 | ||
Enzyme-IN-1 (compound 1), a peptide-based inhibitor of N-terminal nucleophile (Ntn) hydrolases, specifically targets and inhibits the chymotrypsin-like activity (CT-L) of the 20S proteasome. This compound may possess pot... | |||
T77094 | Navivumab | ||
Navivumab (CT-P23) is a monoclonal antibody targeting the hemagglutinin HA of the influenza A virus, effectively neutralizing strains H1, H2, H5, and H9 by binding to the HA2 stem fusion domain [1]. | |||
T80220 | OK2 | EGFR | |
OK2, a specific inhibitor of the CCN2/EGFR interaction, effectively disrupts this interaction by binding to the CT domain of CCN2. It holds potential for use in research pertaining to kidney fibrosis and chronic kidney d... | |||
T77009 | Firivumab | ||
Firivumab (CT-P22; CT120), a human IgG1 monoclonal antibody targeting influenza A virus hemagglutinin (Anti-IAV HA), demonstrates neutralization capabilities against multiple strains including H1N1, H5N1, H6N1, H6N2, H8N... | |||
T75820 | Gap19 TFA | ||
Gap19 TFA is a selective and potent blocker of connexin 43 (Cx43) hemichannels, originating from nine amino acids within the Cx43 cytoplasmic loop (CL). It operates by hindering intramolecular interactions between the C-... | |||
T76851 | Regdanvimab | ||
Regdanvimab (CT-P59) is a human monoclonal antibody designed to target the receptor-binding domain of the SARS-CoV-2 spike protein, thereby inhibiting the virus's ability to enter cells by blocking its interaction with t... | |||
T77148 | Pegdinetanib | ||
Pegdinetanib (BMS-844203; CT-322) is a selective inhibitor targeting VEGFR-2 (VEGFR), exhibiting dissociation constants (Kd) of 11 nM and 250 nM and half-maximal inhibitory concentrations (IC50) of 16 nM and 240 nM for h... | |||
T36848 | Combretastatin A-1 | Combretastatin A1 | Akt , Microtubule Associated |
Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and... |